#USA #Fairfax #Radiopharmaceutical #VirginiaCancer #ASTROTraining

Virginia Cancer Specialists Recognized as a National Training Center

Virginia Cancer Specialists, top-rated in Virginia for cancer care, has recently achieved a significant milestone by being selected as one of the first two Authorized User Training Centers in the United States by the American Society for Radiation Oncology (ASTRO). This recognition not only highlights the practice’s excellence but also addresses an urgent need within the field of radiopharmaceutical therapy (RPT).

The growth in the use of radiopharmaceutical therapy—a targeted approach to cancer treatment—has prompted the ASTRO initiative aimed at overcoming barriers to training access for radiation oncologists. Many practices have the capability to offer RPT but are impeded by a lack of sites and skilled mentors for supervised case training.

Bridging the Training Gap

Dr. Youssef Charara, Chief Medical Physicist at Virginia Cancer Specialists, emphasizes that ASTRO's program is focused on alleviating bottlenecks that limit the adoption of RPT. The new training center allows radiation oncologists to gain the necessary supervised experience through a high volume of cases at Virginia Cancer Specialists, ultimately fostering broader access to innovative treatments for patients nationwide.

Leadership in Radiopharmaceutical Therapy

Under the leadership of esteemed radiation oncologists Dr. Harold C. Agbahiwe and Dr. Gregory S. Sibley, Virginia Cancer Specialists initiated its RPT program in 2014. The journey towards becoming an Authorized User involved navigating extensive supervised training requirements, a process that the new ASTRO program aims to streamline for future providers. Dr. Agbahiwe notes, "The program is designed to mitigate one of the most persistent challenges in achieving supervised training in radiopharmaceutical therapy. By serving as an ASTRO-designated training center, we can empower peers nationwide to introduce this vital therapy into their communities efficiently and safely."

In sharing their expertise and experience, Virginia Cancer Specialists intends to nurture the growth of RPT training across the country. Dr. Sibley highlights the significance of their comprehensive program, stating, "Being selected as a national training center validates the dedication we’ve put into creating a safe and effective therapeutic environment. This venture holds the potential to significantly increase patient access to advanced cancer care."

What the Training Program Will Offer

As an ASTRO-designated training center, Virginia Cancer Specialists aims to provide:

• - Direct hands-on supervised patient case experience.
• - Multidisciplinary mentorship from seasoned radiation oncologists, medical physicists, and nuclear medicine specialists.
• - Comprehensive guidance on the practical implementation of a compliant and safe RPT program.

Advancing Patient Access to Innovative Treatments

Radiopharmaceutical therapy employs targeted radioactive agents to deliver precise radiation to tumors while minimizing damage to surrounding healthy tissue. This technique is particularly beneficial for treating conditions like metastatic castration-resistant prostate cancer and neuroendocrine tumors. With new therapeutic agents and indications emerging swiftly, the demand for efficient training programs is higher than ever.

Virginia Cancer Specialists remains committed to enhancing patient access to cutting-edge treatments and ensuring that new healthcare providers can adopt RPT safely.

For more information or inquiries about the Radiation Oncology Center at Virginia Cancer Specialists, please contact 703-934-4451.

About Virginia Cancer Specialists

Virginia Cancer Specialists is the largest private cancer practice in Northern Virginia, consistently recognized as a leader in cancer care across multiple medical specialties. The practice is dedicated to offering the most advanced treatment protocols for cancer and blood diseases.

Through its affiliation with The US Oncology Network, which includes over 600 care sites across 31 states and thousands of patients involved in clinical trials, Virginia Cancer Specialists is poised to embrace innovations such as those made possible through its collaborations, including its recent partnership with Sara Cannon Research Institute. This collaboration will expand their clinical trial capabilities and enhance patient treatment options across the board. For additional details about Virginia Cancer Specialists and its services, visit their website.